First report of granulomatous mastitis associated with Sjögren’s syndrome by unknown
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Letourneux et al. World Journal of Surgical Oncology 2013, 11:268
http://www.wjso.com/content/11/1/268CASE REPORT Open AccessFirst report of granulomatous mastitis associated
with Sjögren’s syndrome
Christel Letourneux1, Pierre Diemunsch2, Anne-Sophie Korganow3, Cherif Youssef Akladios1,
Jean-Pierre Bellocq4 and Carole Mathelin1*Abstract
Granulomatous mastitis is a rare and often considered as idiopathic disease. However, clinical examination and
thorough diagnostic investigations have to be carried out in order to identify cases that are secondary to infections
or systemic diseases since these forms may be cured with appropriate etiologic treatment. To the best of our
knowledge, this report is the first to describe the association of granulomatous mastitis with Sjögren’s syndrome.
We discuss the clinical, pathological and therapeutic implications of this association.
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Granulomatous mastitis (GM) is a chronic inflammatory
disease of the mammary gland, characterized by recurrent
inflammatory breast tumors of varying sizes, usually unilat-
eral, and without nipple retraction [1]. These tumors can
fistulize with subsequent infection. GMs were studied by
Kessler and Wolloch in 1972 [2]. Only a few hundred cases
have been reported worldwide [3,4], reflecting the low inci-
dence of this disease.
The images obtained with mammography, ultrasound
and magnetic resonance imaging (MRI) are nonspecific and
correspond to heterogeneous masses of variable sizes with
irregular shapes, sometimes confluent, and without atypical
microcalcifications allowing for diagnosis confirmation
[5,6]. Histological examination (microbiopsy or surgical
specimen) is required to obtain a definitive diagnosis.
Within these nodules there is generally a breast inflamma-
tory infiltrate rich in lymphocytes (B and T), plasma cells,
neutrophils and histiocytes. Interestingly, there is some-
times a diffuse infiltration of immunoglobulin (Ig) G4 + cell
type, associated with high serum IgG4 concentration [5].
Sometimes an invasion of the lobules by giant cells associ-
ated with microabscesses can be observed, and outbreaks
of noncaseating necrosis in acini and intralobular ducts can
be associated with the cellular inflammatory infiltrate [7].* Correspondence: carole.mathelin@chru-strasbourg.fr
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distribution, and reproduction in any mediumMost of the time, the GM is considered idiopathic but
there are cases of GMs secondary to infection or systemic
diseases. A wide range of microorganisms have been impli-
cated, and fungi, parasites, as well as bacteria have all been
reported to be causal in GM. However, involved microor-
ganisms are mainly corynebacteria and specifically Coryne-
bacterium kroppenstedtii [8], and Propionibacterium acnes
[8], Mycobacterium tuberculosis [9] and Brucella melitensis
[10]. Thus, a higher prevalence of secondary GMs has been
observed in Mediterranean and Asian countries (China and
Malaysia) [11], probably because of endemic tuberculosis
or brucellosis in these regions.
Secondary GMs have also been reported in association
with sarcoidosis [12], Wegener’s disease [13], systemic
lupus erythematosus [11], erythema nodosum [14] and iso-
lated oligoarthritis [15]. Such GMs that are secondary to
connectivites have usually a favorable outcome when on
corticosteroids [1]. Secondary GMs occur at different ages
depending on the underlying disease with extremes ranging
from 11 to 83 years. Idiopathic GMs are more common in
women of childbearing age, taking oral contraceptives or
close to a period of childbirth or breastfeeding, which raises
the question of hormonal influence, though it has never
been proven [1].
We would like to report a case of association of GM with
Sjögren’s syndrome (SjS). We will review the clinical, diag-
nostic and scalable particularities of this association that
has, to the best of our knowledge, not been described
before.tral Ltd. This is an open access article distributed under the terms of the
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Observation
Mrs NW, age 68, menopausal for 20 years, was sent in May
2008 to the Breast Diseases Center of Strasbourg University
Hospital for the management of a ‘recurrent abscess of the
left breast’ that had been developing since July 2007. She
had suffered four inflammatory lesions spreading succes-
sively in the internal and then external para-areolar area of
her left breast. Neither hyperthermia nor biologic infectious
syndrome was associated with these episodes.
Her past medical history was positive for xerostomia still
treated with a saliva substitute. Our patient neither smoked
nor drank alcohol. Regarding her family, one of her sisters
was treated for nodosa periarthritis associated with
mononeuritis and SjS, whereas her other sister had died at
age 64 after a pulmonary embolism. Also, a cousin had had
breast cancer. Twenty years ago, between 1989 and 1991,
Mrs NW presented with dysesthesia of the upper and lower
limbs with osteotendinous reflexes and sensorimotor
deficit.
The electromyogram (EMG) and peripheral nerve biopsy
were indicative of a mononeuritis. The brain MRI uncov-
ered two lesions of demyelination. Biological investigation
of autoimmunity proved positive for antinuclear antibodies
(ANA) of speckled pattern and anti-SS-A and SS-B anti-
bodies. The findings included also a rheumatoid factor and
polyclonal hyperglobulinemia. By contrast, antineutrophilFigure 1 Histological sections of breast nodules examined after hema
of nodular arrangement (×40). (B and C) Multiple confluent granulomas ric
Lobulite lymphocytic and granulomatous (D ×100 and E ×200). (F) Periduc
lymphocytes (×400).cytoplasmic antibodies (ANCAs) were negative and IgG4s
were not detected in the blood.
Treatment with corticosteroids and plasma exchange did
not improve her sensory disorders.
All of her four breast lesions were successively treated by
surgical excisions (in July, September and December 2007
and March 2008). Histological examination of the surgical
specimens concluded that the lesions of chronic
galactophoritis were associated with granulomatous inflam-
matory lesions (Figure 1). The search for Corynebacterium
andMycobacterium tuberculosis proved negative on specific
media. Superinfection of the lesions by multisensitive
Staphylococcus led to order long-term treatment with
pristinamycin, amoxicillin and clavulanate and later cipro-
floxacin, but without clinical improvement.
When she first consulted in our Breast Diseases Cen-
ter, the clinical examination of Mrs NW was remarkable
for a radial and retractable scar in the mid-outer quad-
rant of her left breast associated with a fistula in the
inferolateral quadrant (Figure 2). No lesion of the right
breast was observed. Mammography and breast ultra-
sound showed no lesion suggestive of breast cancer but
typical aspects of the scarred areas. Carcinoma antigen
(CA) 15.3 assay was normal at 13.8 IU/ml. The rest
of the examination revealed xerophtalmia without
xerostomia (a positive Schirmer test), Raynaud’s syn-
drome in the upper limbs, discrete bilateral basaltoxylin and eosin staining. (A) Chronic granulomatous inflammation
h in multinucleated giant cells (B ×100 and C ×400). (D and E)
tal inflammation rich in neutrophils, macrophages and
Figure 2 Photography of the breasts. (A) Breast face. (B) Left breast in profile showing a radial and periareolar scar in the mid-outer quadrant
and a periareolar scar and an internal fistula in the inferolateral quadrant. No lesions were noted on the right breast.
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Salivary gland biopsy had found a lymphoplasmacytic in-
filtrate of grade IV according to Chisholm’s classification
[16] (Figure 3). The EMG confirmed a mononeuritis, the
brain MRI highlighted lesions suggestive of demyelination
with inflammatory aspects, and chest scan showed diffuse
bronchiectasis-type lung damage. Autoimmunity evaluation
results were superimposable to those obtained twenty years
earlier. The diagnosis of SjS with its neurological complica-
tions was established on clinical (ocular symptoms, a posi-
tive Schirmer test), histological (biopsy of the salivary
glands) and biological arguments (positiveness of ANA and
of anti SS-A and SS-B antibodies). Reiterated inflammatory
breast lesions simultaneously associated with histological
granulomas had led to the diagnosis of GM. The diagnosis
of a GM secondary to SjS was therefore hypothesized. Local
treatment and systemic treatment with corticosteroids
allowed for the healing of the breast lesions without further
surgery. Four years later, clinical stability of the SjS was con-
firmed without any new outbreak of GM.Figure 3 Histological biopsies of salivary glands examined after hema
inflammatory foci (focus: nodular clusters of at least 50 cells) associated wit
classification of Chisholm and Mason (×100). (B) It shows an intense infiltra
especially surrounding the acini and the ducts (×400).Discussion
This article describes the case of a patient presenting simul-
taneously with both GM and SjS. SjS is an autoimmune dis-
ease characterized by chronic lymphocytic infiltration and
destruction of exocrine glands [17]. Patients complain of
xerophthalmia, xerostomia, xerodermia, xerorhinia and va-
ginal dryness. Nonglandular manifestations are reported in
one case in two and appear to be related to lymphocytic in-
filtration and/or leukocytoclastic vasculitis. Our patient had
multiple extraglandular manifestations involving the neuro-
logical system together with a sensory polyneuropathy, and
respiratory tract with a bronchiectasis. The prevalence of
SjS in the general population is 0.1 to 0.6% with a female
preponderance and two frequency peaks according to age:
one between 20 and 30 years and the other, more import-
ant, around 50 to 55 years. Our patient was 68 years old
when she was referred to our Breast Diseases Center, but
her disorders suggestive of SjS dated back to 20 years earl-
ier. As in 70% of the cases of SjS, her biology revealed posi-
tive for anti-SS-B and anti-SS-A antibodies. A rheumatoid
factor is present in 60% of the cases of SjS. Pure forms oftoxylin and eosin staining. (A) Note the presence of multiple
h collagen fibrosis, corresponding to a level 4 according to the
te of chronic inflammatory lymphocytes and plasma cells, interstitial,
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temic illness. Raynaud’s syndrome - that concomitantly af-
fected our patient - is reported in nearly 20% of the cases of
SjS.
When GM is diagnosed, the therapeutic approach re-
quires first a thorough search for an etiological factor. Upon
this first step, if infectious agents are identified as poten-
tially causal, specific therapy (antibiotic-, antifungal- or
antiparasitic-adjusted) is carried out. In cases where a sys-
temic disease is associated or where the GM is recognized
as idiopathic the treatment consists of corticosteroids.
As far as surgery is concerned, a recent study by
Maffini et al. [18] showed that 50% of the patients had
complete resolution of their symptoms under corticoste-
roids whereas the lesions in the other half remained
stable. The authors therefore advocate surgical absten-
tion. Also, surgery should not be the first-line approach
because of its esthetic and psychological impact. Our pa-
tient was really concerned about the aspect of her left
breast, deeply deformed by large and retractile scars.
Furthermore, in the case of secondary MG, surgery is
regularly followed by recurrences, should the underlying
causal disease remain ignored and untreated.
A causal link between GM and a systemic disease is
considered established when both pathologies developed
simultaneously and recede once the specific treatment of
the given disease had been initiated. Such a causal link
has been reported for secondary GMs in association
with sarcoidosis, Wegener’s disease, giant cell arteritis,
periarteritis nodosa and certain isolated oligoarthritis. In
the case of SjS, this causal link with GM is more difficult
to establish firmly since SjS does not evolve in spurts
and since no specific treatment for SjS has proven its
complete efficiency so far [17]. In addition, from a histo-
logical point of view, there is no such thing as
granulomatous-type reaction in the exocrine glands in
the evolution of SjS. The exocrine glands are actually
destroyed by the lymphocytic infiltrate and immune
complexes. There are granulomas in GMs such as those
found in sarcoidosis, rheumatoid arthritis or even the
Wegener’s granulomatosis.
SjS, however, has been associated with granulomatous
diseases such as granulomatous panniculitis [19], which
corresponds to a skin invasion by noninfectious granu-
lomas, curable with colchicine. Similarly, granuloma
annulare may be associated with SjS [20]. Finally, the
first description of three cases of SjS associated with
granulomatous hepatitis was published in 2006 [21]. An
infiltration by lymphoplasmocytes with histiocytes and
epithelioid granulomas was found in the periportal and
lobular part of the liver. These hepatic lesions were re-
duced under azathioprine and corticosteroid treatment.
In our observation, a combination of factors was strongly
suggestive of a causal link between SjS and GM.Conversely, the patient’s age seems too old for idiopathic
GM, which occurs more readily in the fourth decade and is
frequently correlated with hormonal changes (pregnancy,
lactation, oral contraceptives and so on). No hormonal tak-
ing was reported in this patient. Moreover, as far as her rel-
atives were concerned, one of her sisters was followed for
SjS associated with nodosa periarthritis, a disease that
causes secondary GM. On the biological side, our patient
had hyperglobulinemia at diagnosis of SjS, which was also
observed in the GM. Finally, the existence of other granu-
lomatous diseases (skin or liver) during the evolution of SjS
indicates the possibility of developing inflammatory granu-
lomas outside the exocrine glands.
Conclusion
Our observation summarizes the medical history of a 68-
year-old patient presenting with concomitant GM and SjS.
To the best of our knowledge, this is the first report of this
association. The surgical approach of the GM that was pro-
posed as a first-line treatment proved inefficient and led to
recurrences and severe esthetic sequels. The medical ap-
proach based on corticosteroids eventually solved both
pathologies without further surgery.
This case stresses the fact that, in the presence of GM,
the idiopathic nature of the disease should only be ad-
mitted after a careful search for a causal morbid associ-
ation, particularly of infectious or systemic nature.
Etiological treatment of the underlying pathology is as-
sociated with simultaneous healing of the breast illness.
Surgery should be reserved as a second-line option only.
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